agenda 2023 09 22 508
Document text
FINAL - September 19, 2023 MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) Centers for Disease Control and Prevention Atlanta, Georgia 30329 September 22, 2023 AGENDA ITEM 10:00 Welcome and introductions 10:30 Introduction 10:40 RSVpreF Vaccine Safety Surveillance in Pregnancy from The Vaccine Safety Datalink Maternal RSV vaccine safety monitoring in the VAERS and V- safe 11:10 Economic analysis of RSVpreF maternal vaccination 11:30 Economics of Preventing RSV Disease among US Infants by Maternal Vaccination Prior to Birth 12:00 EtR Framework Updates: Pfizer Maternal RSVpreF Vaccine 12:30 Updated clinical considerations for use of both nirsevimab and Pfizer RSVpreF vaccine 12:40 Implementation considerations for maternal RSV vaccine 2:05 Vaccines for Children Resolution 2:20 Break 2:30 Public comment 2:50 Break 2:55 Recommendation and VFC votes 3:20 Adult and Pediatric Immunization Schedule Addendum PRESIDER/PRESENTER(s) Dr. G race Lee (ACIP C hair) Dr. Mel inda Wharton ( ACIP E xecutive Secretary, C DC) Dr. S arah L ong (A CIP, W G Chair) Dr. M alini DeSilva ( HealthPartners I nstitute) Dr. P edro M oro (C DC/NCEZID) Dr. D avid H utton (University o f Michigan) Dr. I smael O rtega-Sanchez (CDC/NCIRD) Dr. K atherine F leming-Dutra ( CDC/NCIRD) Dr. J efferson J ones (CDC/NCIRD) Dr. G eorgina Peacock ( CDC/NCIRD) Dr. Jeanne Santoli (CDC/NCIRD) Dr. Sarah Schillie (CDC/NCIRD) 4:00 Adjourn Acronyms CDC Centers for Disease Control and Prevention CMS Centers for Medicare and Medicaid Services COVID-19 Coronavirus disease 2019 EtR Evidence to Recommendations Framework FDA Food and Drug Administration GRADE Grading of Recommendations Assessment, Development and Evaluation HRSA Health Resources and Services Administration IHS Indian Health Service NCHHSTP National Center for HIV, Hepatitis, STD and TB Prevention [of CDC/DDID] NCIRD National Center for Immunization & Respiratory Diseases [of CDC/DDID] NCEZID National Center for Emerging and Zoonotic Diseases [of CDC/DDID] NIAID National Institute of Allergy and Infectious Diseases OIDP Office of Infectious Disease and HIV/AIDS Policy RSV Respiratory Syncytial Virus SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2 VAERS Vaccine Adverse Event Reporting System WG Work Group WHO World Health Organization VaST COVID-19 Vaccine Safety Technical (VaST) Work Group VE Vaccine Effectiveness